Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI), is pleased to provide investors with the following Operational Update post the closing of our recent $40MM financing.
Cannabis News
Dr. Michael Nashat Appointed President & CEO of TerrAscend
TerrAscend Corp. (CSE: TER) is pleased to announce the appointment of TerrAscend's co-founder and Chief Operating Officer, Dr. Michael Nashat, as the Company's new President & Chief Executive Officer, effective January 22, 2018.
Organigram Announces $100 Million Bought Deal Financing
Company intends to leverage proceeds to solidify leadership position within domestic and global cannabis markets
CanniMed Therapeutics Inc. Announces Strategic International Cannabis Distribution Agreement with Fagron NV
Sumtra Diversified Inc. Enters into Letter of Intent with MJardin Group Relating to a Reverse Takeover Transaction
Canopy Rivers closes oversubscribed $26 million financing via private placement
Canopy Growth Corporation (TSX:WEED) is pleased to announce that its partly owned subsidiary, Canopy Rivers Corporation has closed a non-brokered private placement offering of 23,636,363 Class B common shares at a price of $1.10 per Share. Pursuant to the offering,
Aphria increases revenue 39% and Kilograms(1) sold 45% in quarter
Aphria Inc. (TSX: APH or USOTCQB: APHQF) today reported its results, for the second quarter ended November 30, 2017
Turnkey Cannabis Cultivation Company MJardin to Go Public in Canada
Sumtra Diversified Inc. Enters into Letter of Intent with MJardin Group Relating to a Reverse Takeover Transaction
MedReleaf Corp. Announces $100.7 Million Bought Deal Financing
MedReleaf Corp. (TSX:LEAF) announced today that it has entered into an agreement with Canaccord Genuity Corp. and GMP Securities L.P., pursuant to which the Underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 3,800,000 units of the Company at a price of $26.50 per Unit for aggregate gross proceeds of $100.7 million.
CannTrust™ Reports Record Revenue for Q4 and FY 2017
CannTrust Holdings Inc. (CSE: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation ("ACMPR") program, today is pleased to report preliminary revenue for Q4 and the fiscal year ending December 31, 2017.
Copy of DOJA Cannabis Closes $12.5 Million Private Placement led by Aphria
DOJA Cannabis Company Limited (CSE: DOJA) is pleased to announce the closing of its previously announced non-brokered private placement of subscription receipts whereby Aphria Inc. (TSX:APH and US OTC: APHQF) and Koicha Partners LP acquired from DOJA an aggregate of 8,992,807 Subscription Receipts of the Company at a price per Subscription Receipt of $1.39for gross proceeds of $12,500,001.73.
DOJA Cannabis Closes $12.5 Million Private Placement led by Aphria
DOJA Cannabis Company Limited (CSE: DOJA) is pleased to announce the closing of its previously announced non-brokered private placement of subscription receipts whereby Aphria Inc. (TSX:APH and US OTC: APHQF) and Koicha Partners LP acquired from DOJA an aggregate of 8,992,807 Subscription Receipts of the Company at a price per Subscription Receipt of $1.39for gross proceeds of $12,500,001.73.
Hydropothecary Announces $100 Million Public Offering
The Hydropothecary Corporation (TSX VENTURE:THCX) announced today that it has entered into an agreement with Canaccord Genuity Corp., Eight Capital, and a syndicate of underwriters pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 25,000,000 units of the Company at a price of $4.00 per Unit for aggregate gross proceeds of $100,000,000. Each Unit will consist of one common share and one half of one common share purchase warrant of the Company.
Aphria secures additional 120,000 kgs of expected annual cannabis production for January 2019(1)
Aphria enters strategic relationship with local grower and accelerates capacity increase by over one year
Copy of Hydropothecary Announces $100 Million Public Offering
The Hydropothecary Corporation (TSX VENTURE:THCX) announced today that it has entered into an agreement with Canaccord Genuity Corp., Eight Capital, and a syndicate of underwriters pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 25,000,000 units of the Company at a price of $4.00 per Unit for aggregate gross proceeds of $100,000,000. Each Unit will consist of one common share and one half of one common share purchase warrant of the Company.
Harvest One Announces $25 Million Bought Short Form Prospectus Offering of Units
Harvest One Cannabis Inc. (TSX VENTURE:HVST) is pleased to announce that is has entered into an agreement with Mackie Research Capital Corporation, on its own behalf and behalf of a syndicate of Underwriters, to complete a $25,000,000 short form prospectus offering of units of the Company on a bought deal basis, at a price of $1.82 per Unit.